Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain

Neurochemistry International

Volumn 43, Issue 7, 2003, Pages 603-609

  Subhash, M N ^a   Nagaraja, M R ^a   Sharada, S ^a   Vinod, K Y ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Alpha adrenoceptors; Rat brain; Tricyclic antidepressants; 3H Prazosin; 3H Clonidine

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMITRIPTYLINE; CLOMIPRAMINE; CLONIDINE; DESIPRAMINE; IMIPRAMINE; PRAZOSIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

EID: 0042208202     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(03)00097-4     Document Type: Article

References (63)

1. Ahlquist R.P. A study of the adrenotropic receptors. Am. J. Physiol. 153:1948;586-600.
2. Arango V., Underwood M.D., Mann J.J. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol. Psychiatry. 39:1996;112-120.
3. Arango V., Underwood M.D., Mann J.J. Serotonin brain circuits involved in major depression and suicide. Prog. Brain Res. 136:2002;443-453.
4. Auerbach S.B., Lundberg J.F., Hjorth S. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology. 34:1995;89-96.
5. 2 adrenoceptors in the rat brain. Mol. Pharmacol. 42:1992;846-855.
6. Callado L.F., Meana J.J., Grijalba B., Pazos A., Sastre M., Garcia-Sevilla J.A. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J. Neurochem. 70:1998;1114-1123.
7. Charney D.S., Menkes D.B., Heninger G.R. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch. Gen. Psychiatry. 10:1981;1160-1180.
8. Cordi A.A., Berque-Bestel I., Persigand T., Lacoste J.M., Newman-Tancredi A., Audinot V., Millan M.J. Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties. J. Med. Chem. 44:2001;787-805.
9. 3H ]Spiroperidol label serotonin receptors in rat cerebral cortex and hippocampus Eur. J. Pharmacol. 49:1978;201-202.
10. De Paermentier F., Mauger J.M., Lowther S., Crompton M.R., Katona C.L., Horton R.W. Brain alpha-adrenoceptors in depressed suicides. Brain Res. 757:1997;60-68.
11. Dinan T.G. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction? J. Clin. Psychiatry. 57:1996;14-18.
12. Esteban S., Llado J., Sastre-Coll A., Garcia-Sevilla J.A. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 360:1999;135-143.
13. 2O PET study of the neuromodulatory effects of clonidine Biol. Psychiatry. 49:2001;317-325.
14. Garcia-Sevilla J.A., Zubieta J.K. Activation and desensitization of presynaptic alpha-2 adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens. Br. J. Pharmacol. 89:1986;673-683.
15. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. Arch. Gen. Psychiatry. 47:1990;125-132.
16. Garcia-Sevilla J.A., Escriba P.V., Ozaita A., La Harpe R., Walzer C., Eytan A., Guimon J. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J. Neurochem. 72:1999;282-291.
17. 2 adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J. Neurochem. 83:1994;256-265.
18. Gonzalez-Maeso J., Rodriguez-Puertas R., Meana J.J., Garcia-Sevilla J.A., Guimon J. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors. Mol. Psychiatry. 7:2002;755-767.
19. Gorman J.M., Sullivan G. Noradrenergic approaches to antidepressant therapy. J. Clin. Psychiatry. 61(Suppl. 1):2000;13-16.
20. Gurguis G.N., Vo S.P., Griffith J.M., Rush A.J. Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome. Psychiatry Res. 89:1999;73-95.
21. Hauger, R.L., Rehavi, M., Angel, I., Janowksy, A., Skolnick, P., Poul, S.M., 1998. Receptor-mediated mechanism of antidepressants drug action in psychiatry. In: Michef, R., Cavanar, J.D. (Eds.), Psychobiological Foundation of Clinical Psychiatry, vol. 3. Lippincott, Philadelphia, pp. 1-22.
22. 1 adrenoceptors in the frontal cortex of the rat. Neuropharmacology. 31:1992;955-960.
23. Hsiao J.K., Agren H., Bartko J.J., Rudorfer M.V., Linnoila M., Potter W.Z. Monoamine neurotransmitter interactions and the prediction of antidepressant response. Arch. Gen. Psychiatry. 44:1987;1078-1083.
24. 1 receptors (exvivo radio-receptor binding studies). J. Neural Transm. 89:1992;61-69.
25. Invernizzi R.W., Parini S., Sacchetti G., Fracasso C., Caccia S., Annoni K., Samanin R. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex. Br. J. Pharmacol. 132:2001;183-188.
26. Jimenez-Rivera C.A., Segarra O., Santacana G., Hoffman T., Savage D.D., Weiss G.K. Chronic imipramine treatment induces downregulation of alpha-2 receptors in rat's locus coeruleus and A2 region of the tractus solitarius. Life Sci. 58:1996;287-294.
27. Kalaria R.N., Harik S.I. Increased alfa-2 and beta-2 adrenergic receptors in cerebral micro vessels in Alzheimer disease. Neurosci. Lett. 106:1989;233-238.
28. Katona C.L., Theodorou A.E., Horton R.W. Alpha-2 adrenoceptors in depression. Psychiatry Dev. 5:1987;129-149.
29. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., Ordway G.A. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J. Neurosci. 17:1997;8451-8458.
30. Klimek V., Rajkowska G., Luker S.N., Dilley G., Meltzer H.Y., Overholser J.C., Stockmeier C.A., Ordway G.A. Brain noradrenergic receptors in major depression and schizophrenia. Neuropsychopharmacology. 21:1999;69-81.
31. Lands A.M., Arnold A., McAuliff J.P., Luduena F.P., Brown T.G. Jr. Differentiation of receptor systems activated by sympathomimetic amines. Nature. 214:1967;597-598.
32. Langer S.Z. Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23:1974;1793-1800.
33. Lesch K.P., Manji H.K. Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain. Biol. Psychiatry. 32:1992;549-579.
34. Linner L., Arborelius L., Nomikos G.G., Bertilsson L., Svensson T.H. Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2 adrenoceptor blockade. Biol. Psychiatry. 46:1999;766-774.
35. Lowry O.H., Rosebrough N.J., Farr A.G., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
36. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology. 21:1999;99S-105S.
37. Mateo Y., Fernandez-Pastor B., Menna J.J. Acute and chronic effects of desipramine and clorgyline on alpha2-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study. Br. J. Pharmacol. 133:2001;1362-1370.
38. McPherson G.A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed. 17:1983;107-113.
39. Miralles A., Ribas C., Escriba P.V., Garcia-Sevilla J.A. Chronic clorgyline induces selective downregulation of alpha2-adrenoceptor agonist binding sites in rat brain. Pharmacol. Toxicol. 87:2000;269-275.
40. 2 adrenoceptors on serotonin terminals following long-term treatment with drugs increasing NE synaptic concentration. Neuropsychopharmacology. 10:1994;41-51.
41. x™, 2000. A Comprehensive Reference for Generic and Brand Drugs, 10th ed. Mosby's Publications, St. Louis, MO, pp. III-883-III-885.
42. Murphy D.L., Zohar J., Benkelfat C., Pato M.T., Pigott T.A., Insel T.R. Obsessive compulsive disorder as a 5-HT subsystem related behavioral disorder. Br. J. Psychiatry. 155:1989;15-24.
43. Newman M.E., Miskin I., Lerer B. Effects of single and repeated electroconvulsive shock administration on inositol phosphate accumulation in rat brain slices. J. Neurochem. 49:1987;19-23.
44. 3H ]prazosin binding to different rat brain structures J. Neural Transm. 71:1988;57-64.
45. Ordway G.A. Pathophysiology of the locus coeruleus in suicide. Ann. N.Y. Acad. Sci. 836:1997;233-252.
46. Ordway G.A., Widdowson P.S., Smith K.S., Halaris A. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 63:1994;617-624.
47. Pacheo M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res. 723:1996;37-45.
48. Pilc A., Enna S.J. Synergistic interaction between α and β adrenergic receptors in rat brain slices: possible site for antidepressant drug action. Life Sci. 37:1985;1183-1194.
49. Rehavi M., Ramot O., Yavetz B., Sokolovsky M. Amitriptyline: long-term treatment elevates α adrenergic and muscarinic receptor binding in mouse brain. Brain Res. 194:1980;443-453.
50. Ressler K.J., Nemeroff C.B. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol. Psychiatry. 46:1999;1219-1233.
51. Sacchetti G., Bernini M., Gobbi M., Parini S., Pirona L., Mennini T., Samanin R. Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: study on the role of pre-synaptic alpha2-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol. 363:2001;66-72.
52. Scuvee-Moreau J.J., Dresse A. Effect of various antidepressant drugs on the spontaneous firing rat of locus coeruleus and dorsal raphe neurons of the rat. Eur. J. Pharmacol. 57:1979;219-225.
53. 2 and β adrenoceptors in different regions of rat brain. Neuroscience. 7:1982;1753-1757.
54. 1 adrenoceptor binding sites in rat brain. Eur. J. Pharmacol. 139:1987;259-266.
55. 3H ]5-HT binding sites by N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) in rat brain Neurochem. Res. 23:1998;1321-1326.
56. Svensson T.H., Usdin T. Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: α receptor mediation. Science. 202:1978;1089-1091.
57. Svensson T.H., Dahlof C., Engberg G., Hallberg H. Central pre- and postsynaptic monoamine receptors in antidepressant therapy. Acta Psychiatry Scand. Suppl. 290:1981;67-78.
58. VanderMaelen C.P., Braselton J.P. Acute administration of the antidepressant trazodone increases noradrenergic locus coeruleus neuronal firing in rats. Arch. Int. Pharmacodyn. Ther. 308:1990;13-20.
59. Vetulani J., Nalepa I. Antidepressants: past, present and future. Eur. J. Pharmacol. 405:2000;351-363.
60. 3H ]prazosin binding sites in the rat Brain Res. 310:1984;360-362.
61. 2 adrenoceptors in the rat anococcygeus muscle. J. Neural Transm. Gen. Sect. 82:1990;205-212.
62. Vinod, K.Y., Kassir, S.A., Basavarajappa, B.S., Yalamanchili, R., Arango, V., Mann, J.J., Cooper, T.B., Hungund, B.L., 2002. Upregulation of cannabinoid-1 receptor in the prefrontal cortex of depressed suicide victims. Abstract, Society for Neuroscience, Orlando, USA.
63. Wroblewski B.A., Joseph A.B., Cornblatt R.R. Antidepressant pharmacotherapy and the treatment of depression inpatients with severe traumatic brain injury: a controlled, prospective study. J. Clin. Psychiatry. 57:1996;582-587.